Clinical Research Directory
Browse clinical research sites, groups, and studies.
Proteomic Analysis of Serum Samples After Cardiac Arrest: a TTM-trial Substudy
Sponsor: Region Skane
Summary
Cardiac arrest remains a large contributor to morbidity and mortality. Animal studies suggest an improvement in mortality and neurological function with hypothermia after cardiac arrest, a finding that could not be verified in large clinical trials such as Target Temperature Management after Out-of-hospital Cardiac arrest (TTM) trial. Multimodal neuroprognostication is an important tool for differentiating patients that will recover after cardiac arrest, and currently only one biomarker is in clinical use. The purpose of this study is to explore proteomics profiles in TTM trial patients in order to search for potential novel biomarkers, therapeutic targets, and to explore phenotypes of post-cardiac arrest syndrome.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
682
Start Date
2025-05-22
Completion Date
2025-12-31
Last Updated
2025-06-12
Healthy Volunteers
No
Conditions
Interventions
Proteomic analysis, targeted temperature management
Biobank serum samples from patients that were included in the TTM trial will be used for proteomic analysis. TTM trial randomised patients to targeted temperature management of 33 °C or 36 °C.
Locations (1)
Lund University
Lund, Skåne County, Sweden